Author | James A. Bourgeois, OD, MD


Anti-NMDA Receptor Encephalitis With Visual Hallucinations and Cognitive Impairment

September 15, 2020

In comparison to the classic presentation of schizophrenia, ANMDARE features a later age of onset, female predominance, visual hallucinations, relative lack of cognitive disorganization, and a lack of an extended prodromal period.

Consultation-Liaison Psychiatry: The Interface of Psychiatry and Other Medical Specialties

April 14, 2020

The “tip of the spear" metaphor reflects consultation-liaison’s place as the most forward clinical psychiatry service in the wider medical world that can lead improvements in patient care.

What Psychiatrists Need to Know About the Determination of Dispositional Capacity

April 13, 2018

Some of the most challenging decisional capacity consultations are requests to determine if a patient has the capacity to participate in discharge planning.

Bioethical Challenges for Psychiatrists: Determination of Decisional Capacity

July 26, 2016

The authors parse myths and facts about decisional capacity, with the goal of preserving patients' dignity and autonomy and helping you mediate conflicts, meet bioethical challenges, and provide compassionate resolutions.

The Role of Psychiatrists in HIV Prevention

March 22, 2016

Because over half of persons with HIV infection have a lifetime history of depression or bipolar disorder, psychiatrists are uniquely positioned to provide both preventive and therapeutic interventions to vulnerable patients.

Depression as Co-Pilot: Clinical Implications of Hepatitis C and Interferon/Ribavirin Treatment

April 01, 2005

Comorbid substance use disorders may complicate treatment for both the hepatologist and psychiatrist. Comprehensive assessment of psychiatric illness and psychopharmacological management may be critical.